Portland Global Advisors LLC Amgen Inc Transaction History

Portland Global Advisors LLC

$793 Million
Q3 2024

A detailed history of Portland Global Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Portland Global Advisors LLC holds 23,550 shares of AMGN stock, worth $6.68 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

23,550

Previous 23,153 1.71%

Holding current value

$6.68 Million

Previous $7.23 Million 4.89%

% of portfolio

0.96%

Previous 0.98%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $122,823 - $133,939	397 Added 1.71%	23,550 $7.59 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $53,601 - $65,139	204 Added 0.89%	23,153 $7.23 Million
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $79,854 - $96,394	-297 Reduced 1.28%	22,949 $6.52 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $46,026 - $51,922	180 Added 0.78%	23,246 $6.7 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $92,926 - $115,370	425 Added 1.88%	23,066 $6.2 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $205,699 - $243,235	960 Added 4.43%	22,641 $5.03 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $271,851 - $331,340	1,204 Added 5.88%	21,681 $5.24 Million
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $244,604 - $310,798	-1,068 Reduced 4.96%	20,477 $5.38 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $7,407 - $8,353	33 Added 0.15%	21,545 $4.86 Million
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $56,293 - $62,644	244 Added 1.15%	21,512 $5.23 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $162,479 - $179,744	741 Added 3.61%	21,268 $5.14 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $266,896 - $305,439	1,342 Added 7.0%	20,527 $4.62 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $251,964 - $295,206	1,187 Added 6.6%	19,185 $4.08 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $156,031 - $173,105	668 Added 3.85%	17,998 $4.39 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $42,384 - $49,392	191 Added 1.11%	17,330 $4.31 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $27,047 - $32,208	125 Added 0.73%	17,139 $3.94 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $51,623 - $57,409	-220 Reduced 1.28%	17,014 $4.32 Million
Q2 2020 Jul 23, 2020	BUY	$197.81 - $242.74 $15,824 - $19,419	80 Added 0.47%	17,234 $4.07 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $133,764 - $177,407	-734 Reduced 4.1%	17,154 $3.48 Million
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $71,710 - $92,172	-379 Reduced 2.07%	17,888 $4.31 Million
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $13,058 - $15,646	75 Added 0.41%	18,267 $3.54 Million
Q2 2019 Jul 26, 2019	BUY	$166.7 - $195.41 $522,271 - $612,219	3,133 Added 20.8%	18,192 $3.35 Million
Q1 2019 Apr 15, 2019	BUY	$180.87 - $203.88 $22,066 - $24,873	122 Added 0.82%	15,059 $2.86 Million
Q4 2018 Jan 23, 2019	BUY	$178.4 - $208.25 $50,487 - $58,934	283 Added 1.93%	14,937 $2.91 Million
Q3 2018 Oct 23, 2018	BUY	$185.29 - $208.89 $5,002 - $5,640	27 Added 0.18%	14,654 $3.04 Million
Q2 2018 Jul 31, 2018	BUY	$166.05 - $186.51 $34,206 - $38,421	206 Added 1.43%	14,627 $2.7 Million
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $57,436 - $67,122	-339 Reduced 2.3%	14,421 $2.46 Million
Q4 2017 Feb 01, 2018	SELL	$168.79 - $188.59 $35,445 - $39,603	-210 Reduced 1.4%	14,760 $2.57 Million
Q3 2017 Nov 01, 2017	BUY	$167.29 - $191.0 $2.5 Million - $2.86 Million	14,970	14,970 $2.79 Million

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Portland Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portland Global Advisors LLC with notifications on news.

Account

Portland Global Advisors LLC Amgen Inc Transaction History